Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02261233
Other study ID # NCCAM U19 AT006057 Project 1
Secondary ID 5U19AT006057-02
Status Terminated
Phase N/A
First received
Last updated
Start date April 1, 2014
Est. completion date August 31, 2018

Study information

Verified date January 2019
Source Michigan State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of postural control of the trunk. In order to accomplish this goal, we aim to quantify balance performance in an unstable seated task. Specifically, the investigators will quantify balance performance in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in balance performance after a single session of osteopathic manipulative treatment as well as after 4 sessions of osteopathic manipulative treatment and this improvement will be greater than any learning effect.

A secondary objective of this study is to quantify differences in patient-oriented outcome measures (e.g., self-reported pain, disability) in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in these self-reported outcomes following osteopathic manipulative treatment. The association between improvement in postural control parameters and patient-oriented measures will also be explored.


Recruitment information / eligibility

Status Terminated
Enrollment 63
Est. completion date August 31, 2018
Est. primary completion date August 31, 2018
Accepts healthy volunteers No
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria:

All participants must meet all of the inclusion criteria to participate in the study. Below is a list of inclusion criteria for LBP participants:

- Age 21-65 years

- Independently ambulatory

- Able to speak and read English

- Able to understand study procedures and to comply with them for the entire length of the study.

- Willing to be randomized to either immediate or delayed treatment group.

- Musculoskeletal pain - primarily in the low back region

- Pain rating equal to or greater than 3 out of10 as indicated on the Numeric Rating Scale for Pain

- Disability equal to or greater than 26% as indicated on the Oswestry Disability Questionnaire

Exclusion Criteria:

All candidates meeting any of the exclusion criteria at baseline will be excluded from study participation. Exclusion criteria will be self-reported. However, during each treatment session, the physicians will be watching for clinical signs and symptoms not consistent with physical findings that are suggestive of the presence of any of the exclusion criteria. In such a case, further treatment will be discontinued and the subject will be excluded.

Below is a list of exclusion criteria:

- Inability or unwillingness of individual to give written informed consent.

- Physical therapy or any other form of manual medicine (e.g., Osteopathic Manipulative Medicine, Chiropractic Manipulation, etc.), acupuncture or spinal injections within one month prior to study enrollment

- Workers' compensation benefits in the past 3 months or ongoing medical legal issues

- Possibly pregnant

- Obesity (BMI>32)

- Currently using electrical implants (e.g., cardiac pacemakers, drug delivery pumps, etc.)

History of:

- Spinal surgery

- Spinal fracture

- Spinal infection (e.g., osteomyelitis)

- Cancer

Unresolved symptoms from:

- Head trauma

- Inner ear infection with associated balance and coordination problems

- Orthostatic hypotension

- Uncontrolled hypertension

- Vestibular disorder (e.g. vertigo)

Current diagnosis of:

- Significant spinal deformity (e.g., scoliosis > 20 degrees, torticollis)

- Ankylosing spondylitis

- Spondylolisthesis grades III or IV

- Cauda equine syndrome

- Rheumatoid arthritis

- Osteoporosis

- Angina or congestive heart failure symptoms

- Active bleeding or infection in the back

- Blindness

- Seizures

- Neurologic disease (e.g., Parkinson's disease, multiple sclerosis, cerebral palsy, Alzheimer's disease, amyotrophic lateral sclerosis, stroke or transient ischemic attack in the past year, cervical dystonia)

Conditions recognized by a physician any time during the study:

- Significant or worsening signs of neurologic deficit

- Symptoms are not consistent with mechanical findings

- Other conditions impeding protocol implementation

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Osteopathic manipulative treatment
Up to 4 sessions of osteopathic manipulative treatment (once per week)

Locations

Country Name City State
United States MSU Osteopathic Manipulative Medicine East Lansing Michigan
United States Michigan State University Center for Orthopedic Research Lansing Michigan
United States MSU Musculoskeletal Rehabilitation Lansing Michigan

Sponsors (2)

Lead Sponsor Collaborator
Michigan State University National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Radebold A, Cholewicki J, Polzhofer GK, Greene HS. Impaired postural control of the lumbar spine is associated with delayed muscle response times in patients with chronic idiopathic low back pain. Spine (Phila Pa 1976). 2001 Apr 1;26(7):724-30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in postural control Postural control will be assessed in an unstable seated task, in which subjects will be asked to balance on a specially designed seat. The average deviations from the neutral seat position will be measured in degrees. Change from baseline to shortly after first treatment (1-2 days), from baseline to an expected average of week 4, and from week 4 to an expected average of week 8.
Primary Change in trunk muscle reflex latency Subjects will be pulling with their trunk on a cable held by an electromagnet. The electromagnet will be suddenly released. Trunk muscle response to sudden load release will be measured on electromyographical recordings in milliseconds. Change from baseline to shortly after first treatment (1-2 days), from baseline to an expected average of week 4, and from week 4 to an expected average of week 8.
Secondary Change in Patient Reported Outcomes Measurement Information System (PROMIS) Assesses weekly changes in physical function, anxiety, depression, fatigue, sleep, satisfaction with social role, and pain with PROMIS-29 questionnaire. The expected average is weekly for this outcome measure until the end (expected average of 8 weeks).
Secondary Change in concomitant medication Assesses weekly changes in the use of medication for treating low back pain, including the type of medication and the quantity of medication (i.e., number of pills) with a questionnaire. The expected average is weekly for this outcome measure until the end (expected average of 8 weeks).tcome measure until the end, an expected average of 8 weeks.
Secondary Change in Oswestry Disability Index Assesses weekly changes in functional activities related to low back disability with the Oswestry Disability Index questionnaire. The expected average is weekly for this outcome measure until the end (expected average of 8 weeks).
Secondary Change in fear avoidance behavior Assesses weekly changes in fear avoidance behavior using the Fear Avoidance Beliefs questionnaire. The expected average is weekly for this outcome measure until the end (expected average of 8 weeks).
See also
  Status Clinical Trial Phase
Completed NCT03916705 - Thoraco-Lumbar Fascia Mobility N/A
Completed NCT04007302 - Modification of the Activity of the Prefrontal Cortex by Virtual Distraction in the Lumbago N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Recruiting NCT03600207 - The Effect of Diaphragm Muscle Training on Chronic Low Back Pain N/A
Completed NCT04284982 - Periodized Resistance Training for Persistent Non-specific Low Back Pain N/A
Recruiting NCT05600543 - Evaluation of the Effect of Lumbar Belt on Spinal Mobility in Subjects With and Without Low Back Pain N/A
Withdrawn NCT05410366 - Safe Harbors in Emergency Medicine, Specific Aim 3
Completed NCT03673436 - Effect of Lumbar Spinal Fusion Predicted by Physiotherapists
Completed NCT02546466 - Effects of Functional Taping on Static Postural Control in Patients With Non-specific Chronic Low Back Pain N/A
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05156242 - Corticospinal and Motor Behavior Responses After Physical Therapy Intervention in Patients With Chronic Low Back Pain. N/A
Recruiting NCT04673773 - MY RELIEF- Evidence Based Information to Support People Aged 55+ Years Living and Working With Persistent Low-back Pain. N/A
Completed NCT06049251 - ELDOA Technique Versus Lumbar SNAGS With Motor Control Exercises N/A
Completed NCT06049277 - Mulligan Technique Versus McKenzie Extension Exercise Chronic Unilateral Radicular Low Back Pain N/A
Completed NCT04980469 - A Study to Explore the Effect of Vitex Negundo and Zingiber Officinale on Non-specific Chronic Low Back Pain Due to Sedentary Lifestyle N/A
Completed NCT04055545 - High Intensity Interval Training VS Moderate Intensity Continuous Training in Chronic Low Back Pain Subjects N/A
Recruiting NCT05552248 - Assessment of the Safety and Performance of a Lumbar Belt
Recruiting NCT05944354 - Wearable Spine Health System for Military Readiness
Completed NCT05801588 - Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life N/A
Completed NCT05811143 - Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.